Company intelligence / Profile preview

VVector Bio

Marlborough, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

VVector Bio is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the production of viral vectors for gene therapies. The company provides end-to-end services including process development, analytical testing, and cGMP manufacturing for Adeno-Associated Virus (AAV) and Lentivirus (LV) vectors. Based in Marlborough, Massachusetts, VVector Bio aims to address the industry's manufacturing bottlenecks by offering scalable and high-quality vector production solutions. Their leadership team comprises industry veterans with extensive experience in genomic medicines and biologics manufacturing.

Modalities: Gene therapyViral vector
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on VVector Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VVector Bio.

Explore the full profile